INTRODUCTION
Signal-transduction cascades involving seven transmembrane element, G-protein-coupled receptors (GPCRs) require the obligate activation of heterotrimeric G-proteins [1, 2] . Interactions between GPCRs and G-proteins have been assessed and measured by a variety of means, but amongst the most widespread and popular are assays which examine GPCR-induced exchange of GDP for GTP in the nucleotide-binding pocket of the Gprotein [3] , and the subsequent timer-controlled hydrolysis [4] of the terminal phosphate of GTP by the GTPase activity intrinsic to the α subunits of all G-proteins [1, 2] . Although such approaches are relatively easy to perform, they have generally only been useful for GPCRs which interact predominantly with the G i -like subfamily of pertussis toxin-sensitive G-proteins [5] . This reflects a combination of the higher intrinsic guanine nucleotide exchange and GTPase activity of these G-proteins and their relatively high levels of expression. Thus, although agonistinduced turnover of GTP is accepted to occur on other Gproteins, direct demonstration of this is often difficult or impossible without purification of the components and their reconstitution in artificial vesicles [6] . This is despite one of the earliest pieces of evidence for an obligate role for GTP hydrolysis in signal transmission being derived from analysis of β-adrenoceptor activation of G s in avian erythrocytes [7, 8] .
We have recently generated a fusion protein between the porcine α #A -adrenoceptor and a pertussis toxin-resistant (Cys$&"
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a small stimulation of high-affinity GTPase activity. Iloprost produced no stimulation of GTPase activity which could be attributed to the IP prostanoid receptor-G i" α fusion. However, the fusion proteins containing either G s α or G i" -G s 6α produced substantially greater stimulation of GTPase activity than the isolated IP prostanoid receptor. Treatment of cells expressing the IP prostanoid receptor-G i" -G s 6α fusion protein with a combination of cholera and pertussis toxins allowed direct measurement of agonist activation of the receptor-linked G-protein.
Normalization of such results for levels of expression of the IP prostanoid receptor constructs demonstrated a 5-fold higher stimulation of GTPase activity when using the G s α-containing fusion protein and a 9-fold improvement when using the fusion protein containing G i" -G s 6α to detect G-protein activation compared with expression of the isolated receptor.
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Gly) mutant of the α subunit of the G-protein G i" [9] [10] [11] . Expression of this fusion protein in COS-7 cells, which were treated with pertussis toxin to prevent any potential interactions between the introduced protein and the endogenously expressed G i -like G-proteins, allowed agonist stimulation of high-affinity GTPase activity [9] [10] [11] . Such results demonstrated direct and productive interactions between the two elements of the fusion protein.
The human IP prostanoid receptor (hIPR) [12] is a typical example of a GPCR which stimulates adenylate cyclase activity via activation of G s α. We have recently demonstrated that coexpression of a FLAG (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys)-tagged form of hIPR (FhIPR) and a chimaeric G-protein (G i" -G s 6α) in which the C-terminal six amino acids of G i" α were replaced with the equivalent sequence from G s α, allows robust measures of agonist-stimulation of guanine nucleotide exchange and hydrolysis [13] . In the present study we have generated fusion proteins between FhIPR and the α subunits of its cognate G-protein G s , G i" and the chimaeric G i" -G s 6. After stable expression of these constructs (FhIPR-G s α, FhIPR-G i" α, FhIPR-G i" -G s 6α,) in HEK293 cells, we demonstrate that FhIPR-G s α binds agonist and stimulates adenylate cyclase with the same affinity as the isolated receptor. However, this fusion construct allows substantially greater agonist-dependent stimulation of guanine nucleotide exchange and GTPase activity compared with an equivalent level of expression of the isolated FhIPR in the same cells. Measuring agonist-stimulation of GTPase activity via GPCRs which couple to G s α has traditionally been impractical. These results demonstrate that the use of GPCR-G-protein fusion proteins may provide a useful strategy to overcome this. Enzyme kinetic analysis provided quantitative measurement of the excess agonist-induced G-protein activation derived by maintaining and enforcing close proximity between the two elements of the fusion protein. Simple physical proximity of a GPCR and G-protein is, however, not sufficient to allow effective agonist-mediated information transfer, as FhIPR-G i" α was not activated by agonist. However, the benefit of using a chimaeric G-protein in co-expression studies [13] may be translated directly to the fusion protein context as FhIPR-G i" -G s 6α produced a substantially greater output than FhIPR-G s α. 
MATERIALS AND METHODS

Materials
Construction of FhIPR-G-protein fusion constructs
hIPR cDNA [12] was modified to incorporate the FLAG epitope at the N-terminal of the cDNA [13] . Using FhIPR cDNA, PCR amplification was used to remove the stop codon. At the same time, the last amino acid, cysteine, was changed to glutamic acid due to incorporation of an XhoI restriction site to allow fusion of the G s α cDNA. This fragment of the FhIPR was cloned into the EcoR1\XhoI site of pcDNA3. Rat HA-G s α(L) cDNA (a haemagglutinin-epitope-tagged form of the long isoform of rat G s α) [14, 15] was obtained from Dr. M. J. Levis and Dr. H. R. Bourne, University of California at San Francisco, CA, U.S.A. To enable fusion with the FhIPR cDNA, bases 5h to the open reading frame were changed using PCR to generate an XhoI restriction site, while an XbaI site was incorporated after the stop codon. The sense oligonucleotide used was : 5h-CCGCTCGAGATGGGCT-GCCTCGGCAACAG-3h ; the underlined bases refer to the XhoI digestion site. The antisense oligonucleotide used was : 5h-TGCTCTAGATTAGAGCAGCTCGTATTGGC-3h ;theunderlined bases refer to the XbaI site. The PCR-amplified fragment was digested with XhoI and XbaI and ligated to the FhIPR in pcDNA3 at the XhoI\XbaI sites. G i" -G s 6α was constructed as described previously [13] and generation of the fusion proteins between the FhIPR and both G i" α and G i" -G s 6α was achieved as above.
Cell culture and stable expression HEK293 cells were seeded into 100 mm culture dishes and grown to 60-80 % confluency (18-24 h) before transfection with 5 µg of FhIPR, FhIPR-G s α, FhIPR-G i" α or FhIPR-G i" -G s 6α cDNAs using DOTAP reagent oN-[1-(2,3-dioleoyloxy)propyl]-N,N,Ntrimethylammonium methylsulphateq (Boehringer Mannheim) [13] . Cell lines stably expressing a G418 sulphate (Calbiochem) resistance marker were picked and transferred into 24-well plates. About 40 clones of each cDNA were amplified. Membrane preparations were made [13] and their specific binding of [$H]iloprost was determined.
[ 3 
H]Iloprost binding studies
Binding assays were performed as in [13] 
Immunological studies
The antisera used in this study have been fully described previously [13] . Membrane samples (30 µg\lane) were loaded on to 10 % SDS\PAGE and run overnight at 60 V, 20 mA. Proteins were transferred to nitrocellulose (Schleicher and Schuell), and blocked overnight with 5 % non-fat milk in PBS (0.27 mM KCl\0.15 mM KH # PO % \137 mM NaCl\4 mM Na # HPO % , pH 7.5). The blot was probed with primary antibody\ antiserum in 3 % non-fat milk in PBS for 1 h at room temperature with shaking, washed extensively with PBS containing 0.2 % Nonidet P40 and incubated with secondary antibody in a similar manner.
High-affinity GTPase assays
The assays were performed as described by McKenzie and Milligan [16] with modifications as described by Wise et al. [9] to allow measurement of V max . In a range of studies, cells were pretreated with either cholera toxin (100 ng:ml −" ), pertussis toxin (25 ng:ml −" ) or a combination of these toxins for 24 h prior to cell harvest.
Intact cell adenylate cyclase assays
Intact cell adenylate cyclase assays were performed as described by Merkouris et al. [17] . Cells were split into wells of a 24-well plate and incubated in medium containing [ 
RESULTS
A cDNA encoding FhIPR [13] was modified to remove the stop codon and introduce an XhoI linker sequence at the C-terminal end. The modified cDNA was subsequently ligated to a variant of the long isoform of the α subunit of the G-protein G s [14, 15] . The novel cDNA so generated was designed to encode a 792 amino acid open reading frame consisting of an FhIPR-G s α fusion protein. Equivalent fusion constructs were made between the FhIPR and both full-length G i" α, a G-protein which this GPCR fails to interact with and activate in co-expression studies [13] , and a chimaeric G-protein, G i" -G s 6α [13] , in which the last six amino acids of G i" α were replaced with the equivalent sequence from G s α, with which this GPCR has been shown to interact effectively [13] .
Both the isolated FhIPR and FhIPR-G s α fusion protein cDNAs were expressed stably in HEK293 cells. (Table 1) . A number of clones expressing each construct displayed good levels of specific binding of this ligand. Non-specific binding, as defined by the presence of 10 µM iloprost, was less than 5 % of the measured total binding when using 10 nM [$H]iloprost. Confirmation of expression of the full-length FhIPR-G s α and the FhIPR was demonstrated in immunoblots. The anti-FLAG antibody M5 specifically identified a band of some 90 kDa in membranes of clones expressing FhIPR-G s α, but not in cells expressing FhIPR where the predominant band identified was of some 60 kDa (Figure 1, top) . A polypeptide of the same size as the anti-FLAG M5 antibody-detected FhIPR-G s α was also identified, only in appropriate clones, by antiserum CS which is directed against the final ten amino acids of G s α [18] (Figure 1, top) . Antiserum CS also identified two polypeptides of 47 and 45 kDa which represent long and short splice variant forms of endogenous G s α (Figure 1,  top) . These forms of G s α were also present in membranes of cells expressing the FhIPR (Figure 1 , top) and in parental HEK293 cells (results not shown). Both FhIPR-G i" α and FhIPR-G i" -G s 6α were also expressed stably in HEK293 cells (Table 1) . Immunoblotting studies with the anti-FLAG M5 antibody detected appropriately sized polypeptides (Figure 1, bottom) . Antiserum CS and antiserum I1C, which identifies an internal epitope that is specific to G i" α, also identified these polypeptides in membranes from clones expressing the appropriate fusion constructs (Figure 1, bottom) . Specific binding of [$H]iloprost to membranes of cells expressing each of FhIPR, FhIPR-G s α, FhIPR-G i" α and FhIPR-G i" -G s 6α could be effectively competed by unlabelled iloprost. Although the measured IC &! for iloprost was not different among FhIPR, FhIPR-G s α and FhIPR-G i α it was slightly higher for FhIPR-G i" -G s 6α (Figure 2) . The competition curve in iloprost self-competition binding assays was more shallow in the membranes expressing the isolated FhIPR (0.64p0.05) than in those expressing the various fusion proteins (0.85p0.09) (P 0.01).
Figure 1 Expression of FhIPR and FhIPR-G-protein fusion proteins : immunological detection
The IPR is an activator of adenylate cyclase. Iloprost caused a concentration-dependent stimulation of cAMP production in (Figure 3) . Interestingly, both FhIPR-
21p0.03 nM) were also able to mediate stimulation of adenylate cyclase in response to iloprost. As we have recently demonstrated the capacity of a stably transfected α #A -adrenoceptor-G i" α fusion protein to activate endogenously expressed forms of G i , as well as the fusion protein partner Gprotein [19] , we wished to ascertain whether the FhIPR-G-protein fusion proteins could activate endogenously expressed G s α as effectively as did the isolated FhIPR. Sustained occupancy of many GPCRs, including the IPR expressed endogenously by neuroblastomaiglioma hybrid NG108-15 cells [20] , can result in downregulation of the G-protein(s) which interact with the receptor (see [21] for review). Cells expressing either FhIPR or FhIPR-G s α were exposed to iloprost (1 µM) for periods up to 
Figure 4 Sustained treatment with iloprost causes downregulation of G s α but not FhIPR-G s α
Cells expressing either the FhIPR (lanes 1-6) or the FhIPR-G s α fusion protein (lanes 7-12) were exposed to iloprost (1 µM) for 0 (lanes 1 and 7) , 0.5 (lanes 2 and 8), 2 (lanes 3 and 9), 4 (lanes 4 and 10), 8 (lanes 5 and 11) or 16 h (lanes 6 and 12). Membranes were prepared, resolved by SDS/PAGE and immunoblotted with antiserum CS to detect G s α. (L) and (S) refer to the long and short isoforms of G s α respectively. Similar results were produced in three further experiments.
16 h. Membranes were prepared and immunoblotted. In both clones very large reductions in G s α immunoreactivity were noted over time (Figure 4 ). Both the long and short splice variants were downregulated with similar time courses. Iloprost had no effect on cellular levels of G s α in parental HEK293 cells (results not shown). In contrast with the effects on cellular G s α levels, sustained iloprost treatment did not result in a downregulation of FhIPR-G s α (Figure 4 ). Indeed, with prolonged exposure to 
Figure 5 Effects of cholera and pertussis toxins on iloprost stimulation of high-affinity GTPase activity
Cells expressing FhIPR (1), FhIPR-G s α (2), FhIPR-G i1 α (3), or FhIPR-G i1 -G s 6α (4) were either untreated (open bars), treated with cholera toxin (100 ng:ml − 1 , 24 h) (stippled bars), treated with pertussis toxin (25 ng:ml − 1 , 24 h) (hatched bars) or with a combination of the two toxins (filled bars) prior to harvest and membrane preparation. The capacity of iloprost (1 µM) to stimulate high-affinity GTPase activity was then measured at 0.5 µM GTP as described in the Materials and methods section. Results represent meanspS.E.M. from three independent experiments performed on separate membrane preparations.
iloprost, levels of FhIPR-G s α actually increased somewhat ( Figure 4 ). The capacity of GPCRs to increase guanine nucleotide exchange and hydrolysis by G s α is notoriously difficult to measure [4] . Addition of iloprost (1 µM) failed to alter high-affinity GTPase activity of membranes of parental HEK293 cells but did produce a limited stimulation in membranes of clones expressing the FhIPR (Table 2 and Figure 5 ). This was not increased by transient co-expression of G s α (Table 2 ). In contrast, in membranes expressing the FhIPR-G s α fusion protein, iloprost caused a robust stimulation of high-affinity GTPase activity (Table 2 and Figure 5 ). The capacity of iloprost to stimulate high-affinity GTPase activity in membranes expressing FhIPR-G i" α was no
Figure 6 Iloprost stimulation of the GTPase activity of FhIPR-G s α and FhIPR-G i1 -G s 6α
Basal high-affinity GTPase activity measured at 0.5 µM GTP and its regulation by various concentrations of iloprost was measured in membranes expressing either FhIPR-G s α (#) or FhIPR-G i1 -G s 6α ($). In the case of FhIPR-G i1 -G s 6α the cells were pretreated with a combination of pertussis toxin (25 ng:ml − 1 ) and cholera toxin (100 ng:ml − 1 ) for 24 h before cell harvest. The results represent meanspS.E.M. of triplicate assays of the stimulation above basal activity from one experiment of three performed.
greater than in those expressing the isolated FhIPR (Table 2 and Figure 5 ), whereas for FhIPR-G i" -G s 6α, 1 µM iloprost again produced a robust stimulation which was substantially greater than that observed for FhIPR-G s α (Table 2 and Figure 5) . Pretreatment of cells with pertussis toxin did not substantially modify the effect of iloprost at the isolated FhIPR nor any of the receptor-containing fusion proteins ( Figure 5 ), excluding the possibility that these GTPase signals derived from inappropriate activation of the endogenous cellular G i population. Cholera toxin treatment causes ADP-ribosylation of G s α and consequently prevents GTP hydrolysis by this G-protein. After cholera toxin treatment of cells expressing the isolated FhIPR, iloprost was no longer able to stimulate high-affinity GTPase activity ( Figure 5 ). The same was true for the FhIPR-G i" α fusion protein ( Figure 5 ). As this protein is not a substrate for cholera toxin these results imply that the iloprost-mediated signal observed in these cells in the absence of toxin treatment must derive from activation of the endogenous G s α population and not from activation of the fusion protein-linked G i" α. The large iloprostmediated stimulation of high-affinity GTPase activity in cells expressing the FhIPR-G i" -G s 6α fusion protein was essentially unaffected by treatment with pertussis toxin, cholera toxin or a combination of the two toxins ( Figure 5 ). The sequence of this chimaeric G-protein defines that it should be a substrate for neither cholera toxin nor pertussis toxin [13] . As such, the lack of effect of pertussis toxin was anticipated and the minor reduction in function following cholera toxin treatment can be attributed to interaction with endogenous G s α (Figure 5) . Therefore the high level of iloprost stimulation of high-affinity GTPase activity following treatment of the cells with a combination of cholera and pertussis toxins must represent activation only of the fusion protein-linked chimaeric G-protein ( Figure 5 ). Cholera toxin treatment also essentially abolished the iloprost-mediated signal in cells expressing the FhIPR-G s α fusion protein ( Figure 5 ). However, as this protein should be a direct substrate for cholera
Figure 7 Effects of iloprost on the enzymic properties of FhIPR and FhIPR-G-protein fusion proteins
Basal high-affinity GTPase activity (#) and its regulation by iloprost (1 µM) ($) were measured at various concentrations of GTP in membranes expressing FhIPR (top), FhIPR-G i1 -G s 6α (middle) or FhIPR-G s α (bottom). Results are presented as Eadie-Hofstee transformations from representative experiments of three performed for each construct.
Table 3 FhIPR-G s α-containing fusion proteins allow substantially greater activation of high-affinity GTPase activity than the isolated FhIPR
Membranes of cells expressing the FhIPR, the FhIPR-G s α fusion protein or the FhIPR-G i1 -G s 6α fusion protein were used to measure both iloprost (1 µM)-stimulated high-affinity GTPase activity at V max , as in Figure 7 , and the levels of expression of each construct detected by the specific binding of 10 nM (Figure 6 ). Equivalent concentration-effect curves (performed after combined cholera and pertussis toxin treatment to allow only agonist activation of the fusion protein to be recorded) in cells expressing FhIPR-G i" -G s 6α indicated an EC &! l 76.5p6.6 nM ( Figure 6 ). The effects of iloprost on the isolated FhIPR were sufficiently small to preclude generation of acceptable values for agonist EC &! (results not shown). All of the above GTPase activity experiments were performed using a single concentration of GTP (0.5 µM) as substrate. When GTPase activity and its regulation by iloprost (1 µM) was measured at various GTP concentrations, the increase in activity in membranes expressing FhIPR was shown to represent a small increase in V max , without alteration in the K m for GTP (K m basal activity l 0.49p0.03 µM, K m in the presence of iloprost l 0.48p0.04 µM) (Figure 7 , top). The same was true for the much more robust iloprost stimulation of FhIPR-G i" -G s 6α recorded after combined pretreatment with pertussis and cholera toxins (K m basal activity l 0.64p0.03 µM, K m in the presence of iloprost l 0.63p0.03 µM) (Figure 7, middle) . In contrast, iloprost stimulation of high-affinity GTPase activity in membranes expressing FhIPR-G s α represented a combination of an increase in V max and a small increase in the estimated K m for GTP (K m basal activity l 0.52p0.02 µM, K m in the presence of iloprost l 0.67p0.03 µM) (Figure 7, bottom) . When the increase in GTPase at V max was normalized for expression levels of FhIPR, the FhIPR-G s α and the FhIPR-G i" -G s 6α fusion proteins, the fusion proteins were demonstrated to provide 5.3p0.6-fold (for FhIPR-G s α) and 8.5p1.0-fold (for FhIPR-G i" -G s 6α) greater GTPase response to iloprost than the isolated FhIPR (Table 3) .
DISCUSSION
Prostaglandins (PG) and thromboxanes (TX) are locally acting mediators produced from arachidonic acid by the action of cyclo-oxygenases. Five primary active prostanoid metabolites, PGD # , PGE # , PGF # α , PGI # and TXA # function via a family of GPCRs to produce a range of physiological actions. Receptors from all of these groupings have now been cloned [22] . In the case of the IPR, the recent production of mice lacking this receptor [22] has confirmed its central role in the regulation of platelet aggregation and vasodilation, and hinted at contributions to the regulation of inflammation and pain perception.
Detailed analysis of the interactions of a GPCR with Gproteins is often performed by examining the capacity of receptor agonists to promote guanine nucleotide exchange and subsequent hydrolysis by the cellular G-protein population [3] [4] [5] . Although relatively easy to measure for the G i -family G-proteins, such approaches are often hindered by the fact that other G-proteins, such as G s , have low rates of guanine nucleotide exchange. Recent studies have generated fusion proteins between GPCRs and G-protein α subunits because the defined stoichiometry of expression of the GPCR to G-protein as 1 : 1 allows direct measurement of the catalytic efficiency of an agonist at a GPCR to promote the binding and hydrolysis of GTP by the G-protein [9] .
We have suggested that the physical proximity of the receptor and G-protein, which is an inherent feature of the fusion protein approach, might enhance their interaction and thus generate a robust signal in these assays [23] . This appears true, as a fusion protein between the β # -adrenoceptor and G s α, which incorporates a proteolytic cleavage site between the two, produces markedly greater agonist stimulation of GTPase activity before proteolytic cleavage than after [24] . Furthermore, building on the studies of Conklin et al. [25] , which indicated that switching of the extreme C-terminal region of G-protein α subunits can allow alterations in GPCR coupling selectivity, we generated a chimaeric Gprotein in which the last six amino acids of G i" α were replaced by those from G s α and showed effective stimulation of the GTPase activity of this protein by agonist upon co-expression with the FhIPR [13] . Given that Medici et al. [26] have indicated that the predominance of the G-protein C-terminal in GPCR interactions is lost in a fusion protein between the Saccharomyces cere isiae alpha factor receptor Ste2 and a chimaeric yeastmammalian G-protein, we wished to assess both whether direct linkage of a G-protein not normally activated by the FhIPR would now result in functional coupling, and the importance of the C-terminal region in such interactions.
Following stable expression of the FhIPR in these cells, concentration-dependent stimulation of adenylate cyclase could be recorded upon addition of iloprost (Figure 3 ). This was also the case for the FhIPR-G s α fusion protein (Figure 3) . It is unclear from such experiments whether this activity of the fusion protein was derived only from activation of the GPCR-associated G-protein or via activation of the endogenous G s α pool. To assess this we took advantage of previous demonstrations that sustained occupancy of GPCRs can often result in a downregulation of the G-protein(s) α subunits which interact with and are activated by the GPCR [21] . The maintained presence of iloprost on cells expressing either the FhIPR or the FhIPR-G s α fusion protein resulted in a large, time-dependent downregulation of both the long and short splice isoforms of G s α (Figure 4) , indicative of activation of these G-proteins by both GPCR constructs [21] .
Addition of iloprost to membranes expressing the FhIPR did result in a detectable increase in high-affinity GTPase activity (Table 2) . Moreover, this did not result from a limited interaction of the expressed GPCR with the endogenous G i pool, as the effect was not attenuated by prior pertussis toxin treatment of the cells ( Figure 5 ). It did, however, result from activation of G s α, as iloprost stimulation of high-affinity GTPase was prevented by pretreatment with cholera toxin. Interestingly, although the levels of specific binding of [$H]iloprost indicated the FhIPR-G s α fusion protein to be expressed at only some 50 % of the levels of the isolated FhIPR, addition of iloprost resulted in a larger stimulation of high-affinity GTPase. When these values were normalized for GPCR construct expression levels, the effectiveness of iloprost to induce GTPase activity measured at V max was some 5-fold higher for the FhIPR-G s α fusion protein than for FhIPR (Table 3) . Seifert et al. [27] have also noted a marked benefit of using a β # -adrenoceptor-G s α fusion protein to generate agonist-stimulated GTPase activity compared with the isolated GPCR.
Iloprost also caused a small stimulation of GTPase activity in membranes expressing the FhIPR-G i" α fusion protein ( Figure  5 ). However, this did not reflect activation of the G-protein contained within the fusion protein. Cholera toxin pretreatment abolished this effect, an outcome not expected for G i -family Gproteins. Furthermore, the effect of iloprost in these membranes was not blocked by prior pertussis toxin treatment ( Figure 5 ). As such, simple physical proximity resulting from the fusion construction is not sufficient to allow the FhIPR to activate an unnatural partner G-protein in an agonist-dependent manner. The greatest stimulation of activity by iloprost was produced in membranes expressing the fusion protein between the FhIPR and the chimaeric G i" -G s 6α G-protein. This stimulation was little reduced by combined treatment with cholera and pertussis toxins and, as the chimaeric G-protein is designed to be resistant to both these toxins [13] , this indicated the agonist signal to be derived from activation of this GPCR-linked G-protein. Such results are in accord with our recent co-transfection studies [13] , but it is both important and gratifying to note that the basic features of FhIPR activation of each of the natural, unnatural and chimaeric G-proteins appear to be preserved in the fusion proteins used herein. Furthermore, unlike the work of Medici et al. [26] , these studies support a maintained central role for the Gprotein C-terminus in GPCR interactions within the fusionprotein context.
The current experiments offer a novel insight into a way in which to improve detection of activation of specific G-proteins by GPCRs. The capacity to enhance effective guanine nucleotide exchange and hydrolysis in response to agonist ligands not only provides a strategy by which potentially novel agonist ligands can be detected at one of the earliest steps in GPCR-mediated signal transduction, but also indicates that within the FhIPR-Gα fusion proteins both the GPCR and the G-protein fold effectively and retain their capacity to interact appropriately in the presence of ligands.
